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Functionalising the azobenzene motif delivers a
light-responsive membrane-interactive compound
with the potential for photodynamic therapy
applications†
Theodore J. Hester,a Sarah R. Dennison,b Matthew J. Bakerc and Timothy J. Snape*b
When adorned with n-octyl chains azobenzene is able to disrupt a variety of calcein-loaded phospholipid
liposomes. The levels of lysis observed are dependent both on the lipid headgroup and the conformation
of the azobenzene compound. In all cases studied, it has been shown that the cis-conformer is more
membrane-interactive than the trans-conformer, suggesting that this class of molecule could be
optimised for photo-dynamic therapy applications against infectious pathogens.
Introduction
The use of light for the photoisomerisation of azobenzene
(1, Scheme 1) and its derivatives has been exploited in numer-
ous biomedical applications.1 For example, light as a trigger
has been used to induce changes in a molecular assembly for
the controlled release of chemical compounds;2 to drive func-
tional changes in peptides, proteins, nucleic acids, lipids, and
carbohydrates;3 and for the in vivo light-activation of ion chan-
nels for the remote control of neuronal firing which has poten-
tial applications in controlling activity downstream from sites
of neural damage or degeneration.4 Moreover, proteasome
inhibitors, widely used as cytotoxic agents in cancer treatment,
have been prepared through the introduction of a photoswitch-
able azobenzene motif into the molecular structures studied,
giving rise to chemotherapeutic agents that can be switched
on and oﬀ with light.5
The precedent for azobenzene derivatives to be exploited as
light-triggered molecular switches in biological systems
suggested that such a practice might be combined with our
current interests studying the nature of non-covalent inter-
actions between conformationally distinct benzanilides (e.g. 2)
and diarylureas with phospholipid monolayers,6–9 if suitable
changes to the azobenzene motif could be incorporated, as a
way of designing new photodynamic therapeutic agents for
infectious diseases.
Results and discussion
Scheme 1 outlines the approach taken to merge the desired
structural features of 1 and 2 and the subsequent synthesis of
the target compound (4, 73%) using a TEMPO/CuBr-based oxi-
dative coupling of 4-n-octylaniline (3).10 With suitable quan-
tities of the lipophilic azobenzene derivative 4 in hand,
attempts to determine its spectroscopic and conformational
properties were undertaken, prior to studying the interaction
of any isolable conformers with phospholipid membranes.
To determine the response of 4 to UV light, a 0.125 mM
stock solution was prepared in a suitable solvent or water :
solvent mix and spectra recorded every 10 s using 365 nm
irradiation (ESI†). In the absence of UV irradiation, an intense
π–π* transition band at around 330 nm and a weaker n–π*
transition band around 440 nm is observed for trans-4.3
Scheme 1 Azobenzene (1), a lipid-interactive benzanilide (2) and the
conformationally similar azobenzene derivatives studied here (4 and 5),
and their synthesis.
†Electronic supplementary information (ESI) available: Synthesis, characteris-
ation, UV and membrane lysis experiments. See DOI: 10.1039/c5ob00465a
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Following irradiation of 4 with 365 nm light for 180 s a spec-
trum indicative of cis-5 was recorded which possessed a n–π*
transition with a higher intensity compared to the trans-
isomer.3 Despite this diﬀerence, a photostationary equilibrium
is set up meaning that a maximum of ∼85% of the cis-isomer
forms upon irradiation at 330 nm, an observation that was
confirmed by 1H NMR (see below).
To ensure that the observed conformational change was
fully reversible, a relaxation experiment was carried out, as
above, using a 532 nm laser as the light source and the now
“excited” sample of 5 (0.125 mM solution). In this case, after
irradiation with the 532 nm laser using 30 s intervals for
10 min, an identical time-course spectral series was recorded
to that of the original trans-sample (4), indicating that the
n-octyl-functionalised azobenzene (4) was able to switch con-
formations, as anticipated.11
Corroboration of the light-induced conformational switch
was achieved when the experiment was repeated in CDCl3 and
the irradiated sample analysed directly by NMR and compared
to the non-irradiated sample. Similar changes in the UV
spectra to those seen with the other solvents above were
obtained in CDCl3. The changes in the
1H NMR of 4 were com-
pared prior to irradiation, after 21 h of 365 nm irradiation,
and after exposure of the irradiated sample to darkness and
heat or 532 nm light (to promote relaxation back to trans-4).
The spectra (ESI†) show an expected upfield shift occurs upon
irradiation of trans-4,12 giving a spectrum which is consistent
with the cis-conformation (5). Similarly, a switch back to the
trans-conformer (4) occurs with 532 nm light or at 60 °C in the
dark. In all spectra a small amount of the other conformer is
visible, consistent with the UV experiments above. Combined,
these results support that a conformational switch occurs
between trans-4 and cis-5, whereby it switches from trans to cis
at 365 nm and switches back again at 532 nm (or 60 °C in the
dark).
Having confirmed that the azobenzene derivative 4 cleanly
undergoes the expected conformational switch, and that its
relaxation back to the trans-conformer is suﬃciently slow
(>21 h) to enable assays to take place on the individual confor-
mers, attention turned to establish what, if any, interactions
the two conformers have with phospholipid membranes.
Moreover, if the two conformers were able to interact with
phospholipid membranes, it could be determined whether the
results mirror those of the benzanilide conformers of 2
studied previously,6,8 whereby the cis-conformer was shown to
be more membrane interactive than the trans-conformer, pre-
sumably a consequence of both lipid chains inserting into,
and disrupting the membrane, rather than predominantly only
one of the trans-compound.6,8 Furthermore, the light-switch-
ing advantage of the azobenzene series over the N-methylation
state “pseudo-switch” of the amide series means that the com-
pounds could be optimised for photodynamic therapy appli-
cations, especially for topical treatments.
A concentration-dependent calcein-release assay was used
to determine the extent to which the two conformers are able
to lyse liposomes loaded with the fluorescent dye.13 Four inde-
pendent single-lipid liposomes were used which were com-
posed of dimyristoyl phosphatidylethanolamine (DMPE),
dimyristoyl phosphatidylglycerol (DMPG), dimyristoyl phos-
phatidylserine (DMPS) and dimyristoyl phosphatidylcholine
(DMPC), phospholipids which are the main constituents in,
and can therefore act as simple membrane mimics of, Escheri-
chia coli (DMPE) and Staphylococcus aureus (DMPG)14 or cancer
cells (DMPS and DMPC).15 The total lipid concentration used
in the assay was 100 μM, with a P/L ratio ranging from ∼1 : 4
(24 μM) to ∼1 : 33 (3 μM).
The results (Fig. 1) demonstrate that the compounds do
interact with phospholipid membranes, and that there is a sig-
nificant diﬀerence between the two conformers, with cis-5
being more membrane-interactive than trans-4 across all lipids
tested, results which mimic the trend of the benzanilide
analogue too.6,8
The maximal lysis observed occurred with cis-5 and lipo-
somes consisting of DMPS, where a plateau was reached at
12 μM (∼64% lysis) in 1 h, a value that was not superseded
even at double that concentration. These results compare well
to those of cis- and trans-benzanilide (2)6 against DMPE and
DMPG liposomes where, even at the higher concentration of
400 μM, the maximum levels of lysis were 25.0 ± 0.3% and
42.9 ± 0.1% for the trans- and cis-conformers respectively
against liposomes composed of DMPE lipid, and 21.1 ± 0.6%
and 41.9 ± 0.2% for the trans- and cis-conformers respectively
against liposomes composed of DMPG lipid. These can be
compared to the data shown in Fig. 1 (at 12 μM) of 10.41 ±
0.30% and 33.44 ± 0.22% for trans-4 and cis-5 respectively
against liposomes composed of DMPE lipid, and 28.58 ±
Fig. 1 The ability of trans-4 (top) and cis-5 (bottom) to induce mem-
brane leakage using the lipids DMPE (solid black line), DMPG (solid dark
grey line), DMPS (solid light grey line) and DMPC (dotted black line). The
data shown are the average of three independent experiments.
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0.21% and 54.72 ± 0.31% for trans-4 and cis-5 respectively
against liposomes composed of DMPG lipid, suggesting that,
in both cases, the cis-conformer is the most active form at
lysing liposomes. Presumably such a trend occurs because in
the cis-conformation the lipid chains are able to insert into the
lipid bilayer and disrupt the membrane packing. Since conver-
sion of the isomers at or near the membrane is the core
concept here, the behaviour of the isomers in the presence of
lipids was ascertained (ESI†). A simple UV-Vis experiment was
performed in which a spectral series of the azobenzene deriva-
tives were followed over time in the presence of the liposomes
made up from both DMPC and DMPE, and it was shown that
identical series were obtained, in each case, to those of the
series in the absence of the lipids, suggesting that the azo-
benzene derivatives are able to switch their conformations in
the presence of lipids, as required. Since compounds 2, 4 and 5
contain the same lipid side-chains, the diﬀerences observed
between the compounds and diﬀerent liposomes studied is
therefore seemingly dependent on the specific interactions
between the phosphate headgroups and the motif linking the
two adorned benzene rings. Although it is known that hydro-
phobic molecules can disrupt phospholipid membranes, there
is a significant diﬀerence between trans-4 and cis-5 suggesting
that shape plays an important role here too.
As can be seen in Fig. 2, the size of the two conformers
varies such that the distance between the para-positions of the
benzene rings (the location of the alkyl chains) is smallest in
the cis-isomer (∼0.5 nm cf. ∼1.0 nm). This geometry means
that in the cis-conformation, the n-octyl chains are better posi-
tioned to interact with, and disrupt, the membrane packing
(Fig. 2, left – shown for clarity with one molecule, although in
reality clustering of the compounds in the membrane would
most likely occur). Combined with the larger dipole moment
of the cis-isomer enabling larger ion-dipole interactions to take
place between 5 and the negatively charged membrane, makes
the cis-isomer more membrane disruptive than the trans.
Whether studying the azobenzene derivative here, benz-
anilides6,8 ureas,7 or other constructs,16,17 the subtle diﬀerences
in the non-covalent interactions experienced between the par-
ticular molecular motif and the lipid headgroup should aﬀect
the stability of the compound in the membrane, and hence
the level of lysis observed.18–24 For example, the membrane’s
charge varies depending the nature of the phosphate head-
group (i.e. ethanolamine, glycerol, serine and choline in
DMPE, DMPG, DMPS and DMPC, respectively), as does
the exact make-up of the charge, i.e. whether is it net neutral
(zwitterionic) as seen in DMPE and DMPC, negative as seen in
DMPG, or net negative (zwitterionic) as seen in DMPS, and
this makes a diﬀerence in the levels to which the membrane is
lysed.18,19
Such findings demonstrate that the properties of the lipid
polar headgroup are important in such systems and the overall
amount of lysis is governed by a fine balance of interaction
contributions.
Having observed that the cis-conformer is more membrane-
interactive than trans-4 over a 1 h time period, we were inter-
ested in understanding what would happen over an extended
time period of 24 h. This could be important since this is the
sort of time-scale in which a cis → trans relaxation may begin
to take place, and thus if it did whilst the compound was
buried in the membrane, it would further increase the levels
of membrane lysis observed, and its potential as a membrane-
disruptive compound.
Again, a concentration-dependent time course was studied
against all four lipids (ESI†), but representative data can be
seen in Fig. 3 at 12 μM for simplicity.
As seen in Fig. 3, against all lipids the cis-conformer (5) is
more membrane lytic than trans-4, sometimes as much as two-
fold or more, and in most cases, maximal lysis occurs, and a
plateau is reached, around the 3 h time-point. Overall maximal
lysis occurs at ∼80% for cis-5 against DMPS, but interestingly,
Fig. 2 (a) A schematic showing the proposed mechanism for mem-
brane disruption of cis-5 (left, shown, for clarity with one molecule), and
(b) the reversible isomerisation of azobenzene showing its geometry and
dipole changes (right).
Fig. 3 The kinetics of calcein release over time after addition of 12 µM
(P/L = ∼1 : 8) trans-4 (top) and cis-5 (bottom) to 100 µM DMPE (solid
black line), DMPG (dark grey line), DMPC (dotted black line) and DMPS
(light grey line). After 7 hours the sample ceased calcein release and this
did not change over time.
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there appears to be very little, if any, selectivity for liposomes
composed of DMPC between the two conformers. If the diﬀer-
ence between the levels of lysis caused by the cis and trans con-
formers for each time point are calculated, then it can be seen
that, for all cases except the 1 h time-point, both the neutral
(zwitterionic) lipids DMPE and DMPC have the smallest diﬀer-
ence in lysis for the two conformers. This is in contrast to the
two negatively charged lipids DMPG and DMPS, which have
the greatest diﬀerence, and more specifically, the negative
(zwitterionic) lipid DMPS is the most lysed liposome of all
those studied. This diﬀerence provides a handle with which to
potentially prepare compounds which can be photochemically
switched to selectively interact with diﬀerent phospholipid
membranes, and thus be optimised to be selective chemothera-
peutic agents.
Evidently, these subtle diﬀerences in phospholipid head-
groups are able to impart small selectivities in the interaction
of 4 and 5 with the diﬀerent liposomes. However, the time-
point of the plateaus (∼3 h) are not long enough to induce a
cis → trans transition under ambient conditions, and so we
propose that the increased membrane lysis in the case of cis-5
is due to this conformer being able to better interact with the
membrane than trans-4 (Fig. 1) and not due to isomerisation
whilst embedded in the membrane, or hydrophobic eﬀects
alone.
Conclusions
In conclusion, we have shown that an azobenzene motif
adorned with suitable n-octyl chains is able to disrupt a variety
of independent calcein-loaded liposomes composed of four
diﬀerent phospholipids, and that the levels of lysis observed
are dependent both on the lipid headgroup and the confor-
mation of the molecules being studied. In all cases, it has
been shown that the cis-conformer is more membrane-interac-
tive than the corresponding trans-conformer, results which
mimic those of other structurally-related conformational
switches,6,8 suggesting that this class of molecule could be
optimised for photo-dynamic therapy applications.
Future work will look to focus on studying mixed lipid
systems and further adorning the benzene rings with water-
solubilising groups, groups which could also shift the wave-
length of light required to implement the conformational
switch to the visible spectrum,1 as well as introducing charge
to the molecules to increase their interaction with net negative
membranes, as has seen success recently with pyridinium
analogues.9
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